Interim results from ASPIRE, a randomized, open-label, multicenter phase 3 study evaluating carfilzomib, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone in patients with relapsed multiple myeloma: 36

Scientific publication - Journal Article uoadl:2951642 20 Read counter

Description
Contents

Unit:

Faculty of Medicine

Title:

Interim results from ASPIRE, a randomized, open-label, multicenter phase 3 study evaluating carfilzomib, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone in patients with relapsed multiple myeloma: 36

Languages of Item:

English

Abstract:

Empty abstract

Publication year:

2015

Authors:

Stewart, A
Rajkumar, S
Dimopoulos, M
Mihaylov, G
Goranova-Marinova, V
Rajnics, P
Suvorov, A
Jakubowiak, A
San-Miguel, J
Zojwalla, N
others

Journal:

British Journal of Haematology

Volume:

169

Main subject category:

Health Sciences

Persistent URL:

https://pergamos.lib.uoa.gr/uoa/dl/object/2951642

Interim results from ASPIRE, a randomized, open-label, multicenter phase 3 study evaluating carfilzomib, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone in patients with relapsed multiple myeloma: 36

The digital material of the item is not available.